Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity.
about
A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.Allopurinol use in pregnancy in three women with inflammatory bowel disease: safety and outcomes: a case series.Republished curriculum based clinical review: IBD: reproductive health, pregnancy and lactation.Autosomal Dominant Tubulointerstitial Kidney Disease.Successful Pregnancies with Thiopurine-Allopurinol Co-Therapy for Inflammatory Bowel Disease.IBD: reproductive health, pregnancy and lactation
P2860
Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Allopurinol Use during Pregnan ...... Indicative for Teratogenicity.
@ast
Allopurinol Use during Pregnan ...... Indicative for Teratogenicity.
@en
Allopurinol Use during Pregnan ...... Indicative for Teratogenicity.
@nl
type
label
Allopurinol Use during Pregnan ...... Indicative for Teratogenicity.
@ast
Allopurinol Use during Pregnan ...... Indicative for Teratogenicity.
@en
Allopurinol Use during Pregnan ...... Indicative for Teratogenicity.
@nl
prefLabel
Allopurinol Use during Pregnan ...... Indicative for Teratogenicity.
@ast
Allopurinol Use during Pregnan ...... Indicative for Teratogenicity.
@en
Allopurinol Use during Pregnan ...... Indicative for Teratogenicity.
@nl
P2093
P2860
P1433
P1476
Allopurinol Use during Pregnan ...... Indicative for Teratogenicity.
@en
P2093
Christof Schaefer
Evelin Wacker
Katja Stieler
Mary Panse
P2860
P304
P356
10.1371/JOURNAL.PONE.0066637
P407
P577
2013-06-19T00:00:00Z